Glycogen synthase kinase‑3β inhibitor reduces LPS‑induced acute lung injury in mice

Ding,Qi; Liu,Gaoqin; Zeng,Yuanyuan; Zhu,Jianjie; Liu,Zeyi; Jiang,Junhong; Huang,Jianan

doi:10.3892/mmr.2017.7469

Glycogen synthase kinase‑3β inhibitor reduces LPS‑induced acute lung injury in mice

Authors:
- Qi Ding
- Gaoqin Liu
- Yuanyuan Zeng
- Jianjie Zhu
- Zeyi Liu
- Junhong Jiang
- Jianan Huang
View Affiliations

Affiliations: Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Jiangsu 215006, P.R. China, Department of Ophthalmology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China
Published online on: September 12, 2017 https://doi.org/10.3892/mmr.2017.7469
Pages: 6715-6721
Copyright: © Ding et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to examine the role of Wnt signaling in lipopolysaccharide (LPS)‑induced acute respiratory distress syndrome (ARDS). ARDS was induced by LPS and compared in mice treated with either glycogen synthase kinase‑3β inhibitor (GSKI) or PBS. The protein expression levels of interleukin (IL)‑6, IL‑8, tumor necrosis factor (TNF)‑α, IL‑17, IL‑18 and IL‑1β in the bronchoalveolar lavage fluid (BALF) were examined using murine cytokine‑specific enzyme‑linked immunosorbent assays. The accumulation of neutrophils and macrophages in the BALF were detected using flow cytometry. The extent of pathological lesions was evaluated using an immunohistochemical assay. The differentiation of mesenchymal stem cells (MSCs) into type II alveolar (ATII) epithelial cells was analyzed using immunofluorescence staining. Treatment with GSKI led to maintained body weights and survival in mice with LPS‑induced ARDS. Treatment with GSKI effectively reduced the levels of total protein, albumin, IgM and keratinocyte growth factor in the BALF. Smith scores showed that GSKI significantly alleviated LPS‑induced lung injury. GSKI also functioned to reduce inflammatory cell accumulation and pro‑inflammatory cytokine secretion. Finally, it was found that GSKI promoted the differentiation of MSCs into ATII epithelial cells in vivo. Taken together, the GSKI‑treated mice exhibited reduced acute lung injury through inhibited intra‑fluid inflammatory cell infiltration and decreased expression of pro‑inflammatory cytokines, and GSKI increased the differentiation of MSCs into ATII epithelial cells.

View Figures

View References

1	Ware LB and Matthay MA: The acute respiratory distress syndrome. N Engl J Med. 342:1334–1349. 2000. View Article : Google Scholar : PubMed/NCBI
2	Goss CH, Brower RG, Hudson LD and Rubenfeld GD: ARDS Network: Incidence of acute lung injury in the United States. Crit Care Med. 31:1607–1611. 2003. View Article : Google Scholar : PubMed/NCBI
3	Mendez JL and Hubmayr RD: New insights into the pathology of acute respiratory failure. Curr Opin Crit Care. 11:29–36. 2005. View Article : Google Scholar : PubMed/NCBI
4	Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ and Hudson LD: Incidence and outcomes of acute lung injury. N Engl J Med. 353:1685–1693. 2005. View Article : Google Scholar : PubMed/NCBI
5	Quílez ME, López-Aguilar J and Blanch L: Organ crosstalk during acute lung injury, acute respiratory distress syndrome, and mechanical ventilation. Curr Opin Crit Care. 18:23–28. 2012. View Article : Google Scholar : PubMed/NCBI
6	Middelveld RJ and Alving K: Synergistic septicemic action of the gram-positive bacterial cell wall components peptidoglycan and lipoteichonic acid in the pig in vivo. Shock. 13:297–306. 2000. View Article : Google Scholar : PubMed/NCBI
7	Yoshinari D, Takeyoshi I, Koibuchi Y, Matsumoto K, Kawashima Y, Koyama T, Ohwada S and Morishita Y: Effects of a dual inhibitor of tumor necrosis factor-alpha and interleukin-1 on lipopolysaccharide-induced lung injury in rats: Involvement of the p38 mitogen-activated protein kinase pathway. Crit Care Med. 29:628–634. 2001. View Article : Google Scholar : PubMed/NCBI
8	Tanaka S, Nishiumi S, Nishida M, Mizushina Y, Kobayashi K, Masuda A, Fujita T, Morita Y, Mizuno S, Kutsumi H, et al: Vitamin K3 attenuates lipopolysaccharide-induced acute lung injury through inhibition of nuclear factor-kappaB activationce. Clin Exp Immunol. 160:283–292. 2010. View Article : Google Scholar : PubMed/NCBI
9	Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, Gårdlund B, Marshall JC, Rhodes A, Artigas A, et al: Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 366:2055–2064. 2012. View Article : Google Scholar : PubMed/NCBI
10	Huber-Lang MS, Younkin EM, Sarma JV, McGuire SR, Lu KT, Guo RF, Padgaonkar VA, Curnutte JT, Erickson R and Ward PA: Complement-induced impairment of innate immunity during sepsis. J Immunol. 169:3223–3231. 2002. View Article : Google Scholar : PubMed/NCBI
11	Riedemann NC, Guo RF, Neff TA, Laudes IJ, Keller KA, Sarma VJ, Markiewski MM, Mastellos D, Strey CW, Pierson CL, et al: Increased C5a receptor expression in sepsis. J Clin Invest. 110:101–108. 2002. View Article : Google Scholar : PubMed/NCBI
12	Lehmann LE, Novender U, Schroeder S, Pietsch T, von Spiegel T, Putensen C, Hoeft A and Stüber F: Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis. Intensive Care Med. 27:1412–1415. 2001. View Article : Google Scholar : PubMed/NCBI
13	Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, Czura CJ, Fink MP and Tracey KJ: Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammationProc Natl Acad Sci. USA: 99. pp. 12351–12356. 2002; View Article : Google Scholar : PubMed/NCBI
14	Wang Y, Li M, Stadler S, Correll S, Li P, Wang D, Hayama R, Leonelli L, Han H, Grigoryev SA, et al: Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol. 184:205–213. 2009. View Article : Google Scholar : PubMed/NCBI
15	Bouldin CM, Manning AJ, Peng YH, Farr GH III, Hung KL, Dong A and Kimelman D: Wnt signaling and tbx16 form a bistable switch to commit bipotential progenitors to mesoderm. Development. 142:2499–2507. 2015. View Article : Google Scholar : PubMed/NCBI
16	Etheridge SL, Spencer GJ, Heath DJ and Genever PG: Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells. 22:849–860. 2004. View Article : Google Scholar : PubMed/NCBI
17	Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N and Phinney DG: Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA. 100:8407–8411. 2003; View Article : Google Scholar : PubMed/NCBI
18	Yamada M, Kubo H, Kobayashi S, Ishizawa K, Numasaki M, Ueda S, Suzuki T and Sasaki H: Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J Immunol. 172:1266–1272. 2004. View Article : Google Scholar : PubMed/NCBI
19	Kotton DN, Ma BY, Cardoso WV, Sanderson EA, Summer RS, Williams MC and Fine A: Bone marrow-derived cells as progenitors of lung alveolar epithelium. Development. 128:5181–5188. 2001.PubMed/NCBI
20	Gupta N, Su X, Popov B, Lee JW, Serikov V and Matthay MA: Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol. 179:1855–1863. 2007. View Article : Google Scholar : PubMed/NCBI
21	Geburek F, Mundle K, Conrad S, Hellige M, Walliser U, van Schie HT, van Weeren R, Skutella T and Stadler PM: Tracking of autologous adipose tissue-derived mesenchymal stromal cells with in vivo magnetic resonance imaging and histology after intralesional treatment of artificial equine tendon lesions - a pilot study. Stem Cell Res Ther. 7:212016. View Article : Google Scholar : PubMed/NCBI
22	Takaoka Y, Goto S, Nakano T, Tseng HP, Yang SM, Kawamoto S, Ono K and Chen CL: Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) prevents lipopolysaccharide (LPS)-induced, sepsis-related severe acute lung injury in mice. Sci Rep. 4:52042014. View Article : Google Scholar : PubMed/NCBI
23	Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC and Stewart DJ: Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med. 4:e2692007. View Article : Google Scholar : PubMed/NCBI
24	Fang WF, Cho JH, He Q, Lin MC, Wu CC, Voelkel NF and Douglas IS: Lipid A fraction of LPS induces a discrete MAPK activation in acute lung injury. Am J Physiol Lung Cell Mol Physiol. 293:L336–L344. 2007. View Article : Google Scholar : PubMed/NCBI
25	Dong L, He HL, Lu XM, Yang Y and Qiu HB: Modulation of FLT3 signaling targets conventional dendritic cells to attenuate acute lung injury. APMIS. 120:808–818. 2012. View Article : Google Scholar : PubMed/NCBI
26	Matute-Bello G, Winn RK, Jonas M, Chi EY, Martin TR and Liles WC: Fas (CD95) induces alveolar epithelial cell apoptosis in vivo: Implications for acute pulmonary inflammation. Am J Pathol. 158:153–161. 2001. View Article : Google Scholar : PubMed/NCBI
27	Logan CY and Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
28	Gordon MD and Nusse R: Wnt signaling: Multiple pathways, multiple receptors, and multiple transcription factors. J Biol Chem. 281:22429–22433. 2006. View Article : Google Scholar : PubMed/NCBI
29	Troussard AA, Tan C, Yoganathan TN and Dedhar S: Cell-extracellular matrix interactions stimulate the AP-1 transcription factor in an integrin-linked kinase- and glycogen synthase kinase 3-dependent manner. Mol Cell Biol. 19:7420–7427. 1999. View Article : Google Scholar : PubMed/NCBI
30	Jean D, Harbison M, McConkey DJ, Ronai Z and Bar-Eli M: CREB and its associated proteins act as survival factors for human melanoma cells. J Biol Chem. 273:24884–24890. 1998. View Article : Google Scholar : PubMed/NCBI
31	Walton M, Woodgate AM, Muravlev A, Xu R, During MJ and Dragunow M: CREB phosphorylation promotes nerve cell survival. J Neurochem. 73:1836–1842. 1999.PubMed/NCBI
32	Kurosaki T: Checks and balances on developing B cells. Nat Immunol. 4:13–15. 2003. View Article : Google Scholar : PubMed/NCBI
33	Masterson C, Jerkic M, Curley GF and Laffey JG: Mesenchymal stromal cell therapies: Potential and pitfalls for ARDS. Minerva Anestesiol. 81:179–194. 2015.PubMed/NCBI
34	Li J, Huang S, Wu Y, Gu C, Gao D, Feng C, Wu X and Fu X: Paracrine factors from mesenchymal stem cells: A proposed therapeutic tool for acute lung injury and acute respiratory distress syndrome. Int Wound J. 11:114–121. 2014. View Article : Google Scholar : PubMed/NCBI
35	Simonson OE, Mougiakakos D, Heldring N, Bassi G, Johansson HJ, Dalén M, Jitschin R, Rodin S, Corbascio M, El Andaloussi S, et al: In vivo effects of mesenchymal stromal cells in two patients with severe acute respiratory distress syndrome. Stem Cells Transl Med. 4:1199–1213. 2015. View Article : Google Scholar : PubMed/NCBI
36	Grove JE, Lutzko C, Priller J, Henegariu O, Theise ND, Kohn DB and Krause DS: Marrow-derived cells as vehicles for delivery of gene therapy to pulmonary epithelium. Am J Respir Cell Mol Biol. 27:645–651. 2002. View Article : Google Scholar : PubMed/NCBI
37	Liu AR, Liu L, Chen S, Yang Y, Zhao HJ, Liu L, Guo FM, Lu XM and Qiu HB: Activation of canonical wnt pathway promotes differentiation of mouse bone marrow-derived MSCs into type II alveolar epithelial cells, confers resistance to oxidative stress, and promotes their migration to injured lung tissue in vitro. J Cell Physiol. 228:1270–1283. 2013. View Article : Google Scholar : PubMed/NCBI